Therapeutics to open up for Charcot-Marie-Tooth Disease Market

 

Charcot Marie Tooth disease market

The Charcot Marie Tooth disease market is estimated to be valued at US$ 1,208.92 Mn in 2023 and is expected to exhibit a CAGR of 23.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

 

Market Overview:

Charcot Marie Tooth disease, also known as hereditary motor and sensory neuropathy, is a genetic disorder that affects the peripheral nervous system. It causes the nerves outside of the brain and spinal cord (peripheral nerves) to deteriorate over time. This leads to weakness and wasting in the distal muscles of the legs and arms. The main symptoms include muscle weakness and atrophy in the lower legs and forearms, reduced or absent tendon reflexes, and sensory loss and abnormal sensations. The disease is usually inherited, although some cases have no known family history. It can occur at any age but signs and symptoms usually appear from the late teens to early 30s. The specific nerve fibers affected depends on the type and mutation of the gene causing the disease.

 

Market Dynamics:

The increasing awareness and diagnosis rates are expected to drive the growth of the Charcot Marie Tooth disease market over the forecast period. According to the National Institute of Neurological Disorders and Stroke, Charcot-Marie-Tooth disease affects approximately 1 in 2,500 people in the United States. However, most medical professionals are still unaware of this disease. Raising awareness about the condition and its signs and symptoms is important for early diagnosis and treatment. Non-profit organizations like CMTA (Charcot-Marie-Tooth Association) educate patients and physicians through publications, conferences, patient forums and seminars. Early detection can help slow disease progression.

The other driver is the robust pipeline of drugs under research and development. There is no cure for CMT yet but many companies are exploring gene therapy, neurotrophic factors and other innovative treatment approaches that can potentially stop or reverse nerve damage. Some drugs in late-stage clinical trials show promise. This robust pipeline is expected to lead to major treatment breakthroughs in the coming years, boosting market growth.

 

SWOT Analysis

 

Strength: Charcot Marie Tooth Disease Market has growing research and development activities. Increase in awareness regarding CMT disease is boosting the market growth. Rising government funding for research is also positively impacting the market.

 

Weakness: High cost associated with drug development and lack of approved drug therapy are major challenges in this market. Late diagnosis of CMT also acts as a limitation.

 

Opportunity: Favorable government support and initiatives will create new opportunities in the forecast period. Growing geriatric population susceptible to CMT will further boost the market size.

 

Threats: stringent regulations for drug approval and long approval time are major threats. High prevalence of alternative therapies also poses threat to market growth. Lack of skilled healthcare professionals also restrict the market growth.

 

Key Takeaways

 

The global Charcot Marie Tooth Disease Market is expected to witness high growth, exhibiting CAGR of 23.% over the forecast period, due to increasing prevalence of CMT disease globally. As per recent study, CMT affects nearly 1 in 2,500 people worldwide.

 

Regional analysis

 

North America region currently dominates the Charcot Marie Tooth Disease Market owing to increasing R&D investments, supportive government initiatives and presence of key players in the region. Europe is the second largest market due to rising cases of CMT disease. Asia Pacific region is expected to witness fastest growth during forecast period due to increasing healthcare expenditure and growing awareness.

 

Key players analysis

 

Key players operating in the Charcot Marie Tooth Disease Market are Addex Therapeutics Ltd., Affectis Pharmaceuticals AG, Genzyme Corp, Lead Discovery Center GmbH, Pharnext SA, Acceleron Pharma, MedDay Pharmaceuticals, Bristol-Myers-Squibb Company, Inflectis Bio Science Health Company, Helixmith Co., Ltd., and Neurogene Inc. These major players are adopting various inorganic strategies such as collaborations and partnerships to gain higher market share.

 

Read More

https://www.dailyprbulletin.com/charcot-marie-tooth-disease-market-size-share-growth-outlook-2023/


Comments

Post a Comment

Popular posts from this blog

"Global Heparin Market: Current Trends and Future Prospects"

Image
  Heparin, a crucial anticoagulant, has been a mainstay in the pharmaceutical industry for many years. It plays a pivotal role in preventing and treating conditions such as deep vein thrombosis, pulmonary embolism, and various cardiovascular diseases. As we delve into the current state of the heparin market, we will explore the trends, challenges, and opportunities that shape this vital segment of the pharmaceutical industry. Market Overview: The global heparin market has experienced steady growth over the years, driven by an aging population, increasing cases of cardiovascular diseases, and a rising awareness of the importance of anticoagulants in healthcare. Heparin is available in various forms, including unfractionated heparin (UFH) and low molecular weight heparin (LMWH), each with its own set of applications and market dynamics. Trends: 1.      Rising Demand for LMWH : Low molecular weight heparin is gaining popularity due to its ease of administr...
Read more

"Advancements in Cystic Fibrosis Treatment: A Comprehensive Market Analysis"

Image
  The cystic fibrosis market has seen significant advancements and changes in recent years. Cystic fibrosis is a genetic disorder that affects the lungs and digestive system, leading to thick and sticky mucus production that can cause serious respiratory and digestive complications. The introduction of new therapies and treatments, such as CFTR modulators, has revolutionized the management of cystic fibrosis, offering hope and improved quality of life for patients. These drugs target the underlying genetic mutations responsible for the condition, helping to alleviate symptoms and slow disease progression. However, challenges remain in the cystic fibrosis market . Access to these ground-breaking therapies can be limited due to high costs, and ongoing research is needed to develop treatments for all genetic mutations associated with the disease. Additionally, the market continues to evolve as new therapies and innovations emerge. Collaborative efforts between pharmaceutical compani...
Read more

Botanical Packaging is Estimated to Witness High Growth Owing to Growing Environmental Concerns

Image
  Botanical Packaging Market Botanical packaging involves using various plant-based materials like corn starch, wheat starch, soy protein, bamboo, bagasse as raw materials for manufacturing boxes, cartons, bags and wrapping films for packaging applications. These biodegradable materials offer attractive sustainability advantages over traditional petroleum-based plastics. Botanical packaging finds widespread application in food, beverage, pharmaceutical, personal care and homecare industries for primary, secondary and tertiary packaging needs. The global botanical packaging Market is estimated to be valued at US$ 138.24 Bn in 2023 and is expected to exhibit a CAGR of 34% over the forecast period 2024 to 2031.   Market Dynamics: Growing environmental concerns about the menace of plastic pollution have been fuelling adoption of sustainable packaging alternatives globally. One of the key drivers for botanical packaging market is the stringent government policies and regulati...
Read more